Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology.

Trial Profile

Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Bipolar disorders
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 12 Mar 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 12 Mar 2012 Actual patient number (33) added as reported by ClinicalTrials.gov.
    • 12 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top